We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02853331
Brief Title: Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

First Submitted : July 29, 2016
First Submitted that Met QC Criteria : July 29, 2016
First Posted : August 2, 2016 (Estimate)

Results First Submitted : October 18, 2019
Results First Submitted that Met QC Criteria : October 18, 2019
Results First Posted : November 8, 2019

Last Update Submitted that Met QC Criteria : August 17, 2022
Last Update Posted : August 19, 2022